Skip to content
Search AI Powered

Latest Stories

Videos

Navigating the Obstacles to Cannabis Legalization | The Edge ft Sen. Liz Krueger
The Bluntness, Inc.
News

Why She Did It? New York State Sen. Liz Krueger on Spearheading Cannabis Reform

After seven years of consistent effort, cannabis is finally fully legal in New York. This is in no small part thanks to the tireless work of New York State Senator Liz Krueger of the 28th District, who has been a passionate advocate for cannabis legalization over the past several years. 

“It took us seven years to pass the bill here, but we learned a lot over the course of those seven years. We looked at what was working and not working in other states, and tried to get the best model possible built into our legislation,” Krueger says in regards to New York’s recent legalization through the Marijuana Regulation and Taxation Act (MRTA). 


Krueger sat down with The Bluntness’s Gregory Frye for an episode of The Edge to discuss her journey in spearheading cannabis reform in The Empire State.

The History of Krueger’s Cannabis Advocacy in New York

There are many reasons Krueger has backed cannabis legalization so passionately for the past several years, but social justice is certainly at the forefront. Throughout the U.S., Black Americans are 3.64 times more likely to be arrested for cannabis possession than white Americans, and 8 times more likely in New York before legalization.

“The motivation I had to get involved was looking at the statistics in New York from the last decade of who was getting thrown into the criminal justice system for the use of small quantities of cannabis, and it was horrifying to me. It was so radically skewed to young people who were Black and Brown being arrested for cannabis smoking, being moved through the criminal justice system,” Krueger says. 

“Even if they never went to jail on these issues, they ended up with records. They ended up being exposed to police precinct houses, arraignment courts...and we’re talking 90 percent of the people arrested being Black and Brown.”

These people quickly discovered that, for something as small as getting caught with a joint on their person, they could end up losing eligibility for all sorts of things: certain college grants and loans, living with their families in federally funded housing, and not being able to take civil service tests for some of the good-paying jobs that should have been available for their future.

Although Black and Brown teenagers have been arrested for cannabis at exceedingly higher rates than their white counterparts, research has revealed that people are prone to use cannabis at equal amounts regardless of race or gender. 

Once Krueger became aware of the depth of this issue, she immediately recognized it as something fundamentally wrong. She also recognized that prohibiting cannabis wasn’t decreasing use of the plant at all, and the New York government spending about half a billion dollars per year to bust people for low-level cannabis use was doing nothing but ruining lives.

“Maybe we didn’t know this 50 years ago, but we now know that marijuana has less [harmful] health effects on us than alcohol or tobacco, two products that aren’t outlawed in any state in the country, and yet we were approaching cannabis the same way we’d be approaching heroin or fentanyl,” Krueger says, noting that those substances, too, are worthy of conversations. “So, I decided I was going to attempt to draft a law that would make adult-use cannabis legal.”

How Krueger Helped Bring New York’s Medical Cannabis Program to Fruition

Krueger came to the conclusion that she would draft an adult-use cannabis bill before New York even had their medical cannabis program in place, and she had a plan. 

If she put in a bill for adult-use cannabis, no matter how many people called her crazy for it, it would force the governor to support medical cannabis in an attempt to kill the idea of adult-use ever happening in New York.

Three days later, Governor Cuomo signed New York’s first medical cannabis bill, although the program was incredibly restrictive and difficult for patients to access. 

The medical cannabis program in New York has since been redefined along with the new adult-use legislation, allowing for wider access and clear guidelines around hemp and CBD as well. 

For Krueger, the road to cannabis reform in New York was filled with plenty of hurdles and challenges.

She started off with conversations – as many as she could take on. “I talked to everyone. Whoever wanted to talk to me. I had elected officials who would say, ‘Look, I want to be with you, but my community is not there. Will you come and talk to them if I host a town hall meeting?’”

Krueger agreed to every town hall meeting that came her way, prepared for hostility, and while she was occasionally met with rancour, what she discovered was that the majority of the people out there just didn’t have the facts. 

She began coming prepared with credible information and statistics, ready to combat negative stigmas and misconceptions, the most prominent one being that cannabis is a “gateway drug.”

“People have this belief that it will lead to heroin and fentanyl and opioid addiction, and I would try to walk through the research that has shown marijuana is not a gateway drug. Marijuana could be addictive to some people who are prone to addiction, but it has a lower rate of ‘addiction’ than alcohol or tobacco, and it’s mostly psychological and can be gotten over fairly easily,” Krueger says. 

As Krueger continued her research, she also discovered that although cannabis was illegal, it was easier to obtain than alcohol or tobacco at the time – especially for anyone underage.

“That’s what I was told by police all over the state,” Krueger says. “That you need ID to get alcohol or tobacco, but for marijuana, you can use an app and order a delivery to wherever you are in the state of New York in like, twenty minutes. Nobody’s asking your age – nobody’s asking anything, because it’s an illegal process.”

Essentially, Krueger recognized that legalizing cannabis would eliminate the laundry list of risks that goes along with relying on an informal market. 

She also saw that legalization would help the state be more accountable in regards to who is buying and selling cannabis. 

“I would explain to people that if they think they’re worried about marijuana for their kids or other people in their lives, they need to understand that it’s here. It’s just not legal, and they’d be much better off with a legal system.”

The Damage Anti-Cannabis Laws Have Done To New York (And The U.S. As A Whole)

With a legal market, consumers will be able to know exactly what they’re purchasing and what its contents are with the assurance that it’s been medically tested and approved – without feeling like they’ve had to take a massive risk just to get a little weed. 

A legal market also may help get rid of the racist, anti-Mexican connotations that have gone hand in hand with “marijuana” since the 1920s, she says.

“There was a point in history where marijuana was being grown in Mexico and brought over to the U.S., and the U.S. was worried that there was too much economic activity on the Mexican side of the border and was advantaging them, not us,” Krueger says. “That was the 1920s. And yet to this day, you still hear people talking about the ‘evil Mexicans’ and their marijuana.”

Between economic manipulation and police officers having to meet their arrest quotas, cannabis use has been wrongfully targeted throughout the country (and other parts of the world) for decades, and New York hopes to contribute to a new standard that results in a more honest and fair criminal justice system overall. 

“I think cannabis prohibition has done harm to our police and corrections system, because you discourage people who really want to fight crime from wanting these jobs, because they’ll say, ‘I didn’t want to be a police officer so that I’d be busting teenagers for something that I don’t even think is wrong, so I’m not going to do this.’ So you discourage people from going into policing for the right reasons, and then you’ve created this system which just plays on itself over and over again,” Krueger says.

This flawed system not only harms the police officers who want to fight actual crime – it also harms the Black and Brown children who’ve been raised to rightfully distrust the system that wrongfully targets them. 

“It changes how parents teach their children, and then it changes the child’s relationship with the criminal justice system long before they even are making a decision about whether they’d ever think about using marijuana,” Krueger says. 

Krueger recalls an instance from about 25 years ago, when Rudy Giuliani was Mayor of New York City. Krueger was at a work lunch with mostly women when the following discussion came up: How old should your child be when you teach them how to not get killed by the police?

“I went, ‘What is this conversation?’ And the other women go, ‘Oh, you’re white, you guys don’t do this. If you were a Black or Brown parent, you know you have to teach your kids how not to end up getting arrested or shot by a police officer, when whatever is going on has absolutely nothing to do with your child. They’re just there,’” Krueger remembers.

“I go, ‘You actually have a lesson plan?’ ‘Yes. What do white people teach their kids?’ And I said, ‘If you’re in trouble, go look for a police officer.’”

Krueger never forgot that conversation. It was one of the first to make her realize what a real problem this is, and how commonly it has occurred throughout the nation.

New York’s Hope for the MRTA to Function As A Model For Other States

Over the years, Krueger has worked with advocates from drug policy and civil rights organizations to discuss the specific impact that anti-cannabis laws have had on communities of color. She understood their messaging to be quite clear: justice.

Cannabis legalization cannot stand on its own without bringing justice to the communities that have been wrongfully targeted. Legalization is the first step, but it must include efforts to undo some of the harms that befell the communities that had to pay the price for prohibition.

This effort must include investing money from legal cannabis sales back into those communities, sealing and/or expunging criminal records, and providing functional social equity programs for cannabis brands owned by people within these communities – all of which have been included in New York’s adult-use plan.

“I can guarantee you we got some things wrong, and like other states who have gone down this road, we will make adjustments and amendments as we see that something isn’t working correctly,” Krueger says. 

“It never bothers me to recognize that, okay, you tried to do something big? There’s a decent chance you don’t get it completely right the first time out. But that’s why democracy exists – to be dynamic and to change with how things are needed.”

Need a little more Bluntness in your life? Check out our YouTube page

Up Next

image of a circle of doctors and surgeons standing over and looking at a patient on operating room table
New Study Confirms Medical Cannabis Benefits in Cancer Care—Time for Policy to Catch Up
Photo by National Cancer Institute on Unsplash
News

Cannabis & Cancer: The Evidence Is In—So Why Is the Medical Establishment Still Dragging Its Feet?

A new meta-analysis of 10,000+ studies confirms what patients have known for decades: cannabis helps cancer care. The real question now is, when will healthcare and policy finally reflect the evidence?

If you've ever watched a loved one battle cancer—or been on that journey yourself—you already know the harsh truth: the pain is real, the nausea is relentless, the appetite is gone, and the side effects of treatment often feel worse than the disease. So when patients say cannabis helps, it shouldn’t take 10,000 studies for the medical community to take them seriously.

And yet, here we are.

A groundbreaking meta-analysis published in Frontiers in Oncology this month reviewed more than 10,000 peer-reviewed studies covering nearly 40,000 individual data points related to medical cannabis and cancer. The conclusion? Cannabis offers “significant” therapeutic benefits for patients living with cancer—particularly in managing pain, inflammation, appetite loss, and chemotherapy-induced nausea. The research even hints at potential anticancer properties, though that part of the science is still early and evolving.

“Our findings strongly suggest that medical cannabis can significantly improve quality of life for cancer patients,” said Dr. Marcin Chwistek, a palliative care specialist who contributed to the review.

That should be a mic-drop moment. But instead of making headlines, this kind of evidence often gets buried under layers of stigma, regulatory inertia, and pharmaceutical gatekeeping.

What the Study Actually Says (and Why It Matters)

Unlike many smaller or anecdotal reports, this was not a one-off trial or industry-funded white paper. This was the first large-scale systematic review to pull from real-world patient data, clinical trials, lab studies, and pre-clinical research to paint a global picture of how cannabis interacts with cancer care.

Key findings include:

  • Robust support for using cannabis to relieve chronic pain in cancer patients, often with fewer side effects than opioids.
  • Evidence that cannabis can reduce nausea, vomiting, and anorexia caused by chemotherapy.
  • Signals that cannabinoids may have anti-inflammatory and even tumor-suppressing properties—though this area still needs deeper exploration.
  • Patients overwhelmingly reported improved quality of life, including better sleep, reduced anxiety, and improved mood.

So why isn’t this the standard of care yet?

A Legal Industry, Still Treated Like a Crime Scene

Here’s where the frustration—and hypocrisy—kicks in. Despite medical cannabis being legal in 38 U.S. states and a growing list of countries worldwide, patients and doctors alike are operating in a legal gray zone.

  • Federal law in the U.S. still classifies cannabis as a Schedule I drug—on par with heroin.
  • Physicians often lack training or confidence to prescribe cannabis, thanks to outdated curricula and risk-averse healthcare systems.
  • Patients have to self-medicate, navigating dispensary menus without guidance while dodging insurance hurdles and social judgment.

If this were any other drug—especially one backed by thousands of studies—there would be a pharma giant running national commercials, lobbyists pushing legislation, and glossy brochures in every hospital waiting room. But cannabis?

Still controversial.

Still marginalized.

It’s Not Just Medical: It’s Political

The Guardian’s recent coverage of this study rightfully noted the disconnect between mounting scientific evidence and glacial policy change. Cannabis remains a politically charged substance, often debated through the lens of moral panic rather than clinical data.

Even in places where medical cannabis is legal, access is uneven. Many cancer patients—especially in rural, lower-income, or conservative regions—struggle to get legal access or face stigma from their care teams. Others simply can’t afford the out-of-pocket costs because cannabis isn’t covered by insurance.

This isn’t just about science anymore—it’s about power, politics, and who gets to control healthcare narratives.

The Blunt Take: Let the Science Lead, Not the Stigma

We’ve reached the tipping point. The science says cannabis helps. The patients say cannabis helps. So what are we waiting for?

If we’re serious about evidence-based medicine, it’s time to:

  • Deschedule cannabis federally and integrate it into mainstream care.
  • Mandate cannabis education in medical schools and continuing education programs.
  • Fund longitudinal research into cannabis not just as a palliative tool, but as a potential anticancer agent.
  • Give patients access, insurance support, and dignity—without treating them like criminals or guinea pigs.

This isn’t a radical idea. It’s a rational one.

Because if 10,000 studies don’t prove the point, maybe it’s time to stop questioning the plant—and start questioning the system.

Want more radically honest cannabis coverage?

Sign up for The Bluntness newsletter—where we break through the noise with smart takes, deep dives, and unfiltered commentary on the future of cannabis, psychedelics, culture, and commerce.

Image of the famous Welcome to Fabulous Las Vegas Nevada sign in Las Vegas, NV
Nevada’s First Cannabis Lounge Closes—And It’s a Symptom of a Bigger Problem
Photo by David Vives on Unsplash
News

Nevada’s First Cannabis Lounge Closes—And It’s a Symptom of a Bigger Problem

The closure of Nevada’s first state-licensed cannabis lounge, Smoke and Mirrors, highlights the crushing weight of regulation, taxes, and lack of banking support in legal cannabis. Here's what needs to change.

Tags: Cannabis Lounges, Nevada, Cannabis Policy, Legalization, Industry Reform, Small Business

When Smoke and Mirrors, Nevada’s first state-licensed cannabis consumption lounge, opened in early 2024, it was hailed as a major milestone for the state’s adult-use market and a potential blueprint for others across the country. Less than a year later, it's permanently closed.

The lounge, operated by Thrive Cannabis Marketplace and located just off the Las Vegas Strip, represented what many hoped would be the future of cannabis culture: social, normalized, and elevated. But like too many other legal cannabis ventures, it found itself crushed under the weight of impractical regulations and economic policies that seem designed to ensure failure.

“It has become clear that the regulatory framework for cannabis lounges is not currently conducive to operating a financially sustainable business,” the company stated in a press release.
Source: Ganjapreneur

Let’s break down what’s really going on—and what needs to change if we want this industry to thrive.

The Cannabis Lounge Model: A Necessary Evolution

Cannabis lounges are more than just novelty attractions or tourist bait. They’re a critical piece of the post-prohibition puzzle, allowing consumers to enjoy cannabis in safe, social settings—especially those who can’t legally consume at home or in hotels.

But while alcohol lounges and bars are commonplace (and often subsidized through lenient regulation and tax treatment), cannabis lounges are forced to operate with one hand tied behind their backs and a labyrinth of obstacles:

  • No on-site food or alcohol sales in many states.
  • Limited product variety due to packaging and THC caps.
  • No advertising freedom.
  • Confusing zoning laws that keep lounges tucked away and inaccessible.
  • Consumption thresholds/limits
  • No infused food

In essence, we're asking cannabis lounges to operate like restaurants while banning everything that makes restaurants profitable.

Crushing Regulations + No Banking + 280E = Doom Loop

What Smoke and Mirrors faced is not unique—it’s systemic. Legal cannabis businesses are subject to:

  • 280E Tax Code, which prevents them from deducting ordinary business expenses.
  • No access to traditional banking, forcing them to operate in cash or use predatory fintech workarounds.
  • Overregulation, from security mandates to compliance reporting that rivals pharmaceutical operations.

Imagine launching a startup where you're taxed like a drug cartel, regulated like a hospital, and treated like a criminal by your bank. That’s the cannabis playbook.

Cannabis is Legal, But Treated Like It Isn’t

The closure of Nevada’s flagship cannabis lounge sends a clear message: We have legalized cannabis, but we haven’t normalized it. And that disconnect is costing jobs, hurting innovation, and giving illegal markets all the oxygen they need to keep thriving.

Policymakers love to tout tax revenue from cannabis. But they rarely acknowledge that those taxes are paid by business owners bleeding cash, cutting staff, and shuttering shops.

The hypocrisy is loud:

  • Alcohol gets mainstream infrastructure, marketing access, and social acceptance.
  • Cannabis gets loopholes, compliance traps, and stigma.

The Blunt Truth: It’s Time to Stop Punishing Legal Cannabis

If we want legal cannabis to succeed—and we should, for economic, social justice, and public safety reasons—we need to treat it like the legitimate (and growing) industry it is. That means:

  • Rewriting 280E to allow expense deductions like any other business.
  • Opening access to banking and capital markets.
  • Creating regulatory models that foster innovation and growth, not penalize it.

The closing of Smoke and Mirrors should be a wake-up call. Not just for Nevada, but for every state trying to build a legal market while still clinging to prohibition-era mindsets.

We can’t celebrate the end of the drug war while continuing to fight the battle on the balance sheets of cannabis entrepreneurs.

It’s time to stop admiring the problem—and start fixing it.

map of medical and recreational cannabis retailers in state of New York
NY Cannabis Program Under Fire for Misconduct
NY Cannabis Program Under Fire for Misconduct
News

Legal Weed, Legit?

New York State regulators are investigating some of America’s biggest cannabis companies after receiving complaints that they have been selling marijuana to New York dispensaries that comes from unauthorized sources or is grown out of state, an illegal practice that has been called the industry’s open secret.

New York’s legal cannabis program iNew York’s adult-use cannabis market was supposed to be the nation’s model of equity and regulation. Instead, it’s quickly becoming a cautionary tale. And the latest news doesn’t just raise eyebrows—it should set off alarms across the entire industry.

According to an April 7 report byThe New York Times, New York State regulators are conducting a sweeping investigation into some of the biggest cannabis companies operating in the state—Stiiizy, Grön, Mfused, and others—over allegations of using out-of-state or unauthorized cannabis to produce products for legal dispensaries. It’s a practice insiders call inversion—and it’s been the industry’s not-so-secret open secret for years.

And now, it’s blowing up. Just in time for 4/20.

The Heart of the Investigation: Inversion

Let’s not mince words: transporting cannabis across state lines is a federal crime. And yet, it’s alleged that products hitting legal shelves in New York may have originated in places like California, where the weed is cheaper, more abundant, and—critically—outside of New York’s strict licensing and testing frameworks.

In short: New York consumers thought they were buying regulated, tested, locally grown product. What they may have been getting was something else entirely.

Regulators descended unannounced on Omnium Canna, a Long Island-based processor that reportedly works with multiple national brands, including Stiiizy. Omnium’s facilities were searched by state inspectors wearing “compliance” jackets, clipboard in hand—a scene that now reads more like a drug raid than a routine audit.

But this is about more than any one company. It’s about how fragile New York’s entire cannabis supply chain really is.

A System Set Up to Fail?

This investigation shines a light on what many growers and early licensees have been shouting about for months: the system isn’t broken—it was never fully built.

New York’s failure to implement a comprehensive track-and-trace system means that bad actors can skirt regulations with minimal friction. Cannabis inversion isn’t just possible—it’s reportedly widespread. According to the Cannabis Farmers Alliance, 50–70% of the cannabis sold in licensed New York dispensaries could be from illicit or out-of-state sources.

That’s not just a regulatory issue—it’s an existential one. Especially for legal cultivators across the state sitting on product they can’t move while shelves are stocked with questionably sourced vapes and edibles.

The Brands Under the Microscope

Among those implicated:

  • Stiiizy, the California-based vape juggernaut with a checkered past in both legal and illicit markets.
  • Grön, known for edibles.
  • Mfused, To the Moon, Turn, and Waahoo, the latter being a house brand for Omnium.

All the companies have denied wrongdoing. Stiiizy’s CEO insists all of its New York-sold cannabis is grown and processed in compliance with state regulations. Grön went so far as to say they aren’t under investigation at all.

But public statements aside, The Times cites a 2,000+ page whistleblower report containing evidence of suspicious manufacturing volumes, labeling discrepancies, and questionable lab results. There are hints of possible recalls, license revocations, and interstate violations if any of it holds up.

Who Loses? The Farmers. Again.

It’s the New York cannabis growers—the backbone of the industry’s social equity promise—who are getting crushed. After investing millions in compliant facilities, equipment, and staff, many are now watching as cheaper, questionably sourced products dominate shelf space.

And let’s be honest: many of these brands don’t care where the flower comes from, as long as the packaging looks slick and the margins hold.

“We’d be thriving if inversion wasn’t a factor,” says Joseph Calderone of the Cannabis Farmers Alliance. “Instead, we’re being outcompeted by product that, by law, shouldn’t even be here.”

What Now for Regulators?

The Office of Cannabis Management (OCM) has long been accused of being slow to act, overly cautious, and often opaque in its communications. But this investigation—coinciding with the launch of its new Trade Practices Bureau—could signal a shift toward actual enforcement.

The timing, just two weeks before the biggest sales day of the year, is no accident. This is the agency’s warning shot to an industry that’s been treating rules as suggestions.

But the OCM also has its own questions to answer:

  • Why did it take a whistleblower report and media coverage to prompt serious enforcement?
  • Why wasn’t a robust track-and-trace system in place before products hit shelves?
  • And what protections exist for small operators who followed the rules—while others may have gamed the system?

retail shelves stocked with legal cannabis products The mix of in-state and out of state brands at a legal NY dispensary

The Bigger Issue: Trust

This isn’t just a scandal. It’s a credibility crisis.

If consumers can’t trust that legal cannabis is safe, tested, and locally grown… why would they stop shopping illicit?

If small farmers can’t trust that the state will protect them from regulatory manipulation… why would they stay in business?

And if regulators can’t ensure that billion-dollar brands play by the same rules… then what was the point of legalization at all?

New York didn’t legalize weed just to give national brands a new coast to dominate. It did so under the promise of justice, equity, safety, and opportunity.

If those values are still on the table, this is the moment to prove it. Not with more task forces or PR statements—but with enforcement, transparency, and real consequences.

Because let’s face it: if this market keeps running on vibes and loopholes, it won’t just be the growers who go under. It’ll be the promise of legalization itself.


Attribution:
This article was informed by reporting in The New York Times, “New York Investigating Cannabis Companies Over Illegal Marijuana Sales” by Ashley Southall, published April 7, 2025. Read the original here.

Actor/Comedian Awkwafina smoking a joint held with chopsticks
Getting high w/ Awkwafina
Giphy
News

4/20: The Evolution of a Cultural Phenomenon

From countercultural whisper to mainstream celebration, the journey of April 20th—known simply as “4/20”—represents one of the most fascinating cultural shifts of our time. While most things die within a couple years, '420' has persisted and grown in popularity, highlighting its sustained relevance and cultural significance among cannabis enthusiasts.


From countercultural whisper to mainstream celebration, the journey of April 20th—known simply as “4/20”—represents one of the most fascinating cultural shifts of our time. A decade ago, large gatherings at places like the University of Colorado Boulder were common, but administrative bans have since changed the landscape of 4/20 celebrations significantly. What began as coded communication among a small group of California teenagers has transformed into a global phenomenon that transcends its origins, reshaping attitudes, commerce, and policy along the way. While most things die within a couple years, '420' has persisted and grown in popularity, highlighting its sustained relevance and cultural significance among cannabis enthusiasts.

Origins: The Waldos and the Birth of a Code at San Rafael High School

The true genesis of 4/20 cuts against many of the urban legends that surround it. It wasn’t police code for marijuana consumption. It had nothing to do with Hitler’s birthday or Bob Marley’s death. The actual story begins in 1971 in San Rafael, California, with five high school students who called themselves “the Waldos.”

These teenagers—Steve Capper, Dave Reddix, Jeffrey Noel, Larry Schwartz, and Mark Gravich—created the term as a meetup time. They would gather at 4:20 PM by their school's statue of chemist Louis Pasteur to smoke marijuana and search for an abandoned cannabis crop they’d heard about near Point Reyes. Often, this gathering followed their football practice, linking their social activities with the emergence of the term ‘420.’ Their adventure, which they called “the 4:20 Louis,” became routine. Eventually, “4:20” evolved into shorthand for smoking marijuana. A friend's brother, concerned about being caught for growing marijuana, gave the Waldos permission to harvest the weed patch, further contributing to the lore surrounding ‘420.’

The phrase might have remained local slang if not for a crucial connection: Reddix’s brother, a close friend of Phil Lesh, bassist for the Grateful Dead, facilitated the spread of the term. As the Waldos socialized within the band's circle, their code term spread through the Deadhead community and beyond. Additionally, Bob Dylan's song 'Rainy Day Women No. 12 & 35,' with its refrain 'Everybody must get stoned,' also contributed to the cultural context in which the term '420' thrived.

Grateful Dead's Jerry GarciaGiphy

Cultural Ascension: From Underground Code to Global Holiday in Cannabis Culture

By the early 1990s, the term had gained enough traction that High Times magazine embraced and promoted it. A 1991 issue reproduced a flyer inviting people to smoke “420” on April 20 at 4:20 PM, codifying both the time and date within cannabis culture. This was a pivotal moment in the slang spread of ‘420’, as the cannabis magazine High Times played a crucial role in documenting and popularizing the term. Reporter Steve Bloom, while attending a Grateful Dead concert, encountered the flyer that led to the cannabis magazine High Times publishing the story, effectively cementing 4/20's significance as a cannabis holiday. What began as teenage code had evolved into an unofficial holiday.

Fast forward to the early 1990s, the observance spread organically through word of mouth, then accelerated exponentially with the rise of the internet. What’s remarkable about 4/20 is how it grew without corporate backing or institutional support—indeed, despite active prohibition of the substance it celebrated.

The Oxford English Dictionary added the term in 2017, citing documents from the 1970s as the earliest recorded uses. The Waldos saved postmarked letters and other artifacts from the 1970s referencing “420,” which they now keep in a bank vault.

Celebrating Marijuana Culture’s High Holiday

Marijuana culture’s high holiday, 4/20, is celebrated on April 20th every year. The origins of this day trace back to the 1970s with a group of friends from San Rafael High School in California, known as the Waldos. They would meet at 4:20 PM to smoke marijuana and search for a hidden cannabis crop, creating a private lexicon that eventually spread to the wider public.

Today, 4/20 has evolved into a significant event in the cannabis industry, especially in legal weed states. Pot shops offer special deals and promotions, turning the day into a major sales event. Large gatherings in cities across the country mark the occasion, reflecting the holiday’s deep roots in marijuana culture's high holiday.

The White House has shown an openness to marijuana reform, and many states have implemented “social equity” measures to help communities of color benefit from legalization. Recreational pot is now allowed in nearly half of the states and the nation’s capital, with 24 states permitting recreational use and 14 more allowing medical marijuana. Kentucky, for instance, will see its medical marijuana legislation take effect in 2025.

Despite these advancements, marijuana remains illegal under federal law, classified alongside drugs like heroin under Schedule I of the Controlled Substances Act. However, the Biden administration has taken steps toward reform, including pardoning thousands of people convicted of “simple possession.” The Department of Health and Human Services has recommended reclassifying marijuana as Schedule III, which would recognize its medical use under federal law.

Even with the federal government dragging its feet, public support for legalization is also at an all-time high, with a Gallup poll last fall showing 70% of adults in favor.

To commemorate the spread of legalization, 4/20 is now celebrated with large gatherings and events across the country. The Mile High 420 Festival in Denver is one of the largest 4/20 events in the world. Hippie Hill in San Francisco’s Golden Gate Park has also attracted massive crowds. College quads and statehouse lawns are also known for drawing 4/20 celebrations.

Some breweries make 420-themed beers, including SweetWater Brewing in Atlanta. Lagunitas Brewing in Petaluma, California, releases its “Waldos’ Special Ale” every year on 4/20 in partnership with the term’s coiners. The Waldos can be found be at Lagunitas Brewing on 4/20 to sample the beer.

4/20 has become a big industry event, with vendors gathering to try each other’s wares. The holiday has become a mixed bag, with many smaller growers struggling to compete against large producers. Many Americans are still behind bars for weed convictions, despite the legalization movement’s progress.

Most people would describe 4/20 as a time to celebrate victories and strategize for further progress. Others would view 4/20 as a good time, but also acknowledge the importance of continuing to advocate for marijuana reform. Thankfully, the cannabis industry has evolved significantly since the early days of the Waldos.

gif of scene from Reefer Madness; woman smoking weed, black and white movieScene from Reefer Madness Giphy

The Politics of Marijuana Possession

As we examine the cultural impact of 4/20, we must also look at the politics of marijuana possession, which are complex and multifaceted. Proponents of legalization argue that it is a matter of personal freedom and point to the economic benefits and social justice implications of ending prohibition. They highlight the potential for tax revenue, job creation, and the reduction of incarceration rates for non-violent drug offenses. On the other hand, opponents cite concerns about public health and safety, including the potential for increased use among teens and the challenges of regulating cannabis consumption.

As the debate continues, it is clear that the politics of marijuana possession will remain a contentious issue in the United States for years to come. The evolving legal landscape, coupled with shifting public attitudes, suggests that the conversation around marijuana is far from over. The journey from prohibition to normalization and potential federal legalization reflects broader societal changes and the ongoing struggle to balance individual rights with collective well-being.

Commercialization and Mainstreaming

As social attitudes toward cannabis softens and legal barriers fall, 4/20 continues to evolve. What was once a day of defiant celebration has become a prime marketing opportunity. In states with legal cannabis markets, April 20th now drives sales comparable to Black Friday in retail.

Dispensaries offer special promotions, product launches coincide with the date, and cannabis brands build marketing campaigns around the holiday. Consumers take advantage of these specific offers, reaping the benefits of pot-shop discounts available during the celebratory event. Even mainstream companies have cautiously embraced 4/20 with knowing winks in their advertising—Ben & Jerry’s ice cream has offered free samples at 4:20 PM and introduced flavors with playful references to cannabis culture. This year's edition of 4/20 highlights the significance of current events and changes within the marijuana culture, reflecting on the progress made in cannabis legalization and social equity within the movement.

This commercialization reflects the holiday’s journey from counterculture to mainstream. When major corporations acknowledge 4/20, they signal the growing cultural acceptance of cannabis and its associated rituals.

Beyond Consumption: Advocacy and Social Change

While celebration remains central to 4/20, the day has increasingly incorporated activism. Many 4/20 gatherings include speeches on criminal justice reform, medical access, and continued efforts toward legalization. The origins of the term '420' are long murky, with various claims about its meaning, including connections to police codes and cultural references. However, the more widely accepted story is that a group of high school students in California popularized its use.

This dual nature—part celebration, part protest—gives 4/20 a complexity absent from many other cultural observances. In places where cannabis remains criminalized, 4/20 gatherings carry inherent political significance simply by occurring. These events often highlight the historical context of marijuana possession and its ties to the drug war, emphasizing the need for federal pardons and policy changes. In jurisdictions where legalization has happened, the holiday serves as a reminder of both progress made and work remaining.

The evolution of 4/20 parallels and in some ways has driven broader cannabis policy reform. As the holiday gained prominence, it helped normalize discussions about marijuana and challenged stereotypes about its users. Images of diverse crowds peacefully gathering on college campuses and in public parks contrasted sharply with the “dangerous drug user” narrative that has dominated for decades. Efforts to regulate marijuana continue to evolve, with ongoing legislative efforts aimed at allowing more autonomy for states in managing their cannabis laws.

Ritual and Community: The Sociology of 4/20

Beyond consumption, legalization, and commercialization lies perhaps the most enduring aspect of 4/20: community building. The holiday creates spaces where people share experiences across generational, economic, and cultural lines.

Sociologists note that 4/20 exhibits many hallmarks of traditional holidays—shared rituals, special foods (often infused with cannabis), music, and communal gathering. These elements, including the acceptance of cannabis consumption, fulfill deep human needs for belonging and collective experience. The Waldos began hanging out in the circle of the Grateful Dead, which played a significant role in spreading the slang associated with 4/20.

In this way, 4/20 has transcended its origins as merely a time to consume cannabis. For many participants, the day represents belonging to a community with shared values regarding personal freedom, natural wellness, and questioning established norms.

Perhaps most remarkably, 4/20 has transcended its direct association with marijuana to become a broader cultural touchpoint. References to “420” appear throughout film, television, music, and literature—sometimes related to cannabis, but often simply acknowledging the code’s status as shared cultural knowledge. Unlike most things that fade over time, 4/20 continues to thrive and is unlikely to be replaced by any other cannabis-related observance. Someday somebody's attempt to change its significance will likely fail, illustrating its rooted place in culture.

The term has achieved what linguists call “semantic broadening,” expanding beyond literal reference to invoke ideas of counterculture, relaxation, and mild rebellion. Even people who don’t consume cannabis recognize “420” as cultural shorthand, demonstrating how thoroughly it has permeated modern consciousness.

Actor/Comedian Awkwafina smoking a joint held with chopsticksGetting high w/ AwkwafinaGiphy

More Than a Day to Get High

Fifty years after those five teenagers first gathered at 4:20 PM, their improvised code has grown into something they could never have imagined—a globally recognized observance that influences commerce, policy, and culture.

The evolution of 4/20 from secret code to commercialized holiday reflects broader shifts in American society regarding personal freedom, relationship to authority, and attitudes toward altered states of consciousness. It also demonstrates how cultural phenomena in the digital age can spread, evolve, and institutionalize with remarkable speed.

As cannabis continues its journey from prohibition to acceptance, 4/20 will likely continue evolving as well. But its core elements—community gathering, shared ritual, and a spirit of mild rebellion—seem likely to endure, ensuring that even as cannabis itself becomes increasingly normalized, the holiday commemorating it remains special.

What began with five teenagers in California has become a cultural institution, demonstrating how powerfully small acts can ripple through time and society when they capture something essential about human experience and connection.

image of California coast, pacific coast highway at sunset
How Overregulation Crushed California’s Gold Flora—And Why Other States Should Be Worried
Photo by Matthew Hamilton on Unsplash
News

Overregulation Kills Gold Flora

California’s Gold Flora was once a cannabis success story with $100M in annual revenue and 16 dispensaries. Now it’s selling off its assets under court supervision. The real culprit? A brutal cocktail of overregulation, high taxation, and policy missteps. And it’s not just California—other legal markets across the U.S. are showing the same dangerous signs.

When California-based Gold Flora entered the legal cannabis scene, the company was poised to dominate. Backed by serious money and a sprawling, vertically integrated operation—from a 100,000-square-foot cultivation campus in the desert to marquee dispensaries in West Hollywood and San Jose—Gold Flora wasn't just riding the green wave. It was supposed to be the wave.

But by the end of March 2025, the company had filed for receivership, its assets now headed to auction. And while headlines cite "merger woes" and "market conditions," the real culprit behind Gold Flora’s collapse is far more systemic: a regulatory stranglehold that has quietly choked the life out of California’s once-promising cannabis economy.

And California isn't alone. From Colorado to Massachusetts, Michigan to New Jersey, the same pattern is playing out—an industry that was supposed to represent a generational economic boom is buckling under the weight of its own rules.

Legal Cannabis: A Cautionary Tale from the Golden State

Gold Flora’s story reads like a textbook example of how not to build a sustainable cannabis market. Despite $100 million in annual revenue, the company couldn’t outpace its liabilities. Many of those stemmed from its 2023 merger with Jay-Z-backed TPCO—a deal that looked good on paper but brought legal baggage and bloated overhead for the cannabis business.

But let’s be clear: Gold Flora’s real downfall wasn’t bad business. It was bad policy.

California has burdened its legal operators with sky-high taxes, Byzantine licensing processes, and patchwork enforcement that gives illegal players a competitive edge. Cannabis companies, particularly multistate operators, are selective in choosing their operational states due to these macroeconomic challenges. Operators like Gold Flora are expected to run professional, compliant, multimillion-dollar operations—yet they pay a premium for the privilege, all while watching untaxed, unregulated competition thrive. The Department of Cannabis Control's strict regulations and high costs can drive entrepreneurs towards the illegal market.

The state’s refusal to offer any real financial relief, coupled with the federal government’s continued classification of cannabis as a Schedule I drug (which bars companies from bankruptcy protection), makes the situation even more dire. The legal market in California continues to struggle with high taxes and regulatory burdens, despite significant strides since legalization. A court-appointed receiver will now attempt to recoup what they can by liquidating Gold Flora’s assets.

gif of falling dominoes The Dominoes Are Falling Nationwide as Federal Prohibition EndsGiphy

The Dominoes Are Falling Nationwide as Federal Prohibition Ends

The same structural failings are rippling through other legal cannabis markets. The evolving landscape of the adult use cannabis market highlights the importance of regulations and business strategies in various states that have legalized or are considering legalization.

In Colorado, one of the first states to legalize recreational marijuana, wholesale prices have tanked amid oversupply and fierce competition. Cannabis businesses are closing shop at alarming rates, not because demand has waned, but because the math no longer works.

Massachusetts has become infamous for its bureaucratic bottlenecks and licensing delays, particularly impacting smaller and BIPOC-led businesses that were supposed to benefit from the state’s social equity promises. Instead, many are stuck in limbo—burning cash without the ability to operate.

Michigan is facing market saturation without adequate regulation to ensure long-term viability. The result? A race to the bottom on pricing that favors large MSOs (multi-state operators) while squeezing out local entrepreneurs. The medical market also plays a crucial role in the state's cannabis industry dynamics.

New York and New Jersey, the newer members of the adult-use club, have already shown signs of following in California’s footsteps. Despite bold equity-first frameworks, New York’s rollout has been slow and mired in litigation, allowing illicit shops to flourish. Legal operators, many of whom are equity licensees, are struggling to keep the lights on before ever making a sale.

In New Jersey, the licensing backlog and zoning battles have made it nearly impossible for smaller players to launch on time—or at all—while larger corporations move faster through regulatory red tape. The legalization of recreational cannabis has opened up a new customer base, but it also brings complex regulatory challenges and market fluctuations.

But the most absurd—and revealing—comparison lies in how we tax cannabis versus alcohol.

Cannabis Taxes vs. Alcohol Taxes: A Disparity That Defies Logic

Consider this: In Colorado, cannabis taxes raised $396 million in a single year. Alcohol taxes? Just $53 million. That’s nearly 7 times more revenue from cannabis—despite alcohol being more widely consumed and associated with far greater public health costs.

In Massachusetts, cannabis excise taxes brought in $74 million, far outpacing the $51 million generated by alcohol.

Why? Because alcohol is taxed on volume—just 1–2 cents per drink. Cannabis, on the other hand, is often taxed by price, weight, or even THC potency, creating a punitive and volatile tax structure. In New York, cannabis products face a 13% retail tax plus a potency-based excise tax of up to $0.03 per milligram of THC. That’s the equivalent of taxing alcohol based on its ABV—imagine paying more for a strong IPA than a light beer, just because it gets you buzzed faster.

In practice, this means legal cannabis consumers often pay 30%–50% more at checkout due to layered taxes—a major reason why two-thirds of cannabis sales in California still happen in the illicit market.

So while states claim to support legal cannabis, their tax structures say otherwise. They’re bleeding the industry dry while subsidizing its competition.

Overregulation Is Not the Same as Oversight

Let’s be clear: cannabis should be regulated. Cannabis dispensaries play a crucial role in California's evolving market, facing both establishment challenges and regulatory obstacles. But the frameworks emerging across legal states often confuse control with support. Instead of building fertile ground for entrepreneurship, governments have built obstacle courses—stacking taxes, fees, compliance costs, and red tape so high that only the best-capitalized (or luckiest) can survive. Cannabis entrepreneurs initially entered the market with optimism and significant investments, but now face regulatory complexities and market fluctuations.

Ironically, this regulatory overkill is doing the opposite of what it was designed to do. It’s propping up the illicit market. In California, it’s estimated that 2 out of 3 cannabis sales still happen outside the legal system—largely because underground cannabis products are cheaper, more accessible, and often indistinguishable from licensed alternatives to the average consumer.

Federal law creates significant challenges for cannabis businesses, including high operational costs and prohibitive tax rates. Federal prohibition contributes to a fragmented cannabis industry, creating inconsistencies in regulations and increasing operational costs for businesses. The legal operators? They’re not just competing—they’re subsidizing the competition.

Cannabis Industry at a Crossroads

The cannabis industry is not dying—but it is disillusioned. Cultivation operations face significant financial and regulatory challenges, making it difficult for new businesses to thrive. The dream that legalization would automatically lead to prosperity, job creation, and community reinvestment has hit a sobering wall, even as the industry is growing rapidly.

If states want to salvage what’s left of that dream and address the aftermath of efforts to legalize cannabis, they need to shift their approach:

  • Streamline licensing and compliance so smaller, independent operators can enter and stay in the game.
  • Reform cannabis tax structures to bring them more in line with alcohol, making legal products affordable and competitive.
  • Crack down on illicit operators fairly and consistently, instead of using legal businesses as cash cows to fund enforcement.
  • Offer safety nets, such as access to grants, bridge loans, and eventually, bankruptcy protections.
  • Push for federal reform, including bankruptcy protections and fair banking access.

Medical cannabis is also becoming more prevalent, with major companies acquiring dispensaries and retailers across multiple states. Until then, more companies like Gold Flora—once hailed as the future—will quietly implode under the weight of policies that were never built to let them thrive.If Gold Flora—a well-capitalized, vertically integrated company—couldn’t survive under this system, who can?

Until these issues are addressed, more cannabis companies will fall—many quietly, some publicly—but all as casualties of a system that never truly wanted them to succeed.

Recent